| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.31 | 0.08 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |